Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ficara

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Bone Reports|January 16, 2020
Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosisEleonora Palagano, Sharon Muggeo, Laura Crisafulli, et al.
Stem Cell Reports|September 8, 2015
Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional OsteoclastsTui Neri, Sharon Muggeo, Marianna Paulis, et al.
Frontiers in Endocrinology|September 24, 2024
Correction of osteopetrosis in the neonate <i>oc/oc</i> murine model after lentiviral vector gene therapy and non-genotoxic conditioningSara Penna, Alessandra Zecchillo, Martina Di Verniere, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARONadia Lo Iacono, Harry C Blair, Pietro L Poliani, et al.
Blood|January 15, 2026
PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease ProgressionVeronica Vallelonga, Francesco Gandolfi, Matteo Zampini, et al.
Blood|October 25, 2003
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantationElisabetta Zino, Guido Frumento, Sarah Marktel, et al.
Haematologica|January 18, 2020
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosisValentina Capo, Sara Penna, Ivan Merelli, et al.
Nature Communications|April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Elena Riva, Luca Lanino, et al.
Hemasphere|June 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)Giulia Maggioni, Gabriele Todisco, Elisabetta Sauta, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Bone Reports|January 16, 2020
Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosisEleonora Palagano, Sharon Muggeo, Laura Crisafulli, et al.
Stem Cell Reports|September 8, 2015
Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional OsteoclastsTui Neri, Sharon Muggeo, Marianna Paulis, et al.
Frontiers in Endocrinology|September 24, 2024
Correction of osteopetrosis in the neonate <i>oc/oc</i> murine model after lentiviral vector gene therapy and non-genotoxic conditioningSara Penna, Alessandra Zecchillo, Martina Di Verniere, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARONadia Lo Iacono, Harry C Blair, Pietro L Poliani, et al.
Blood|January 15, 2026
PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease ProgressionVeronica Vallelonga, Francesco Gandolfi, Matteo Zampini, et al.
Blood|October 25, 2003
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantationElisabetta Zino, Guido Frumento, Sarah Marktel, et al.
Haematologica|January 18, 2020
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosisValentina Capo, Sara Penna, Ivan Merelli, et al.
Nature Communications|April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Elena Riva, Luca Lanino, et al.
Hemasphere|June 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)Giulia Maggioni, Gabriele Todisco, Elisabetta Sauta, et al.
Pageof 4